Drug · DIN 02393166
OPTIMARK
15 ML SINGLE DOSE PREFILLED SYRINGE
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since March 23, 2018.
- Drug Identification Number (DIN)
- 02393166
- Company (DIN owner)
- Liebel-Flarsheim Canada IncPointe-Claire, Quebec, Canada
- Schedule
- Ethical
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Gadoversetamide V08CA06
- Class
- Human
- Record last updated
- July 30, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GADOVERSETAMIDE | 330.9 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 13, 2015: NOC 16523New Drug Submission (NDS) · Transfer of drug identification numbers
- November 22, 2012: NOC 13878New Drug Submission (NDS) · Manufacturer name change
- September 21, 2012: NOC 13693Supplement to a New Drug Submission (SNDS) · Change of resin for container closure system
Other DINs named OPTIMARK
- DIN 02242986 · Cancelled Post Market
- DIN 02393158 · Cancelled Pre Market
- DIN 02393174 · Cancelled Pre Market
- DIN 02393182 · Cancelled Pre Market